No profile data available.
Jupiter Neurosciences, Inc. (JUNS) is a healthcare company in the brain and nerve treatment drugs industry, based in Jupiter, United States, with about 5 full-time employees.
It reported revenue of $21,796 for fiscal year 2025, and net income of -$8.64 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $24,245. Its market capitalization was $3.76 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements.
Jupiter Neurosciences reported $21,796 in revenue for fiscal year 2025. In Q2 2026 revenue was $24,245.
$3.76 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Enveric Biosciences, Inc. (ENVB), Alzamend Neuro, Inc. (ALZN), Silo Pharma, Inc. (SILO), Psyence Biomedical Ltd. (PBM).